A briefing on clinical advances in ultrasound will be a part of this year’s International Symposium on Focused Ultrasound.
Key data will be presented by experts highlighting the use of focused ultrasound—a non-invasive therapeutic technology—to treat a wide range of disorders, including Parkinson’s, Alzheimer’s, epilepsy, arthritis, breast cancer, pancreatic cancer, soft tissue tumors, brain tumors and hypertension.
The featured speakers will include Dr. Jeff Elias, Professor of Neurological Surgery at the University of Virginia; Dr. Pejman Ghanouni, Assistant Professor of Radiology at Stanford University Medical Center; Dr. Paul Fishman, Professor of Neurology, Pharmacology and Neurobiology at the University of Maryland School of Medicine; and Dr. Joo Ha Hwang, Chief of Gastroenterology at the University of Washington.
The International Symposium on Focused Ultrasound is organized by the Focused Ultrasound Foundation and spotlights leading edge preclinical, translational and clinical research. Targeted to scientists, clinicians, and other stakeholders, the conference offers a multifaceted exploration of the focused ultrasound field and featured plenary sessions, panel discussions, poster presentations and technical exhibits.
“Our goal is to create an environment at the symposium that is conducive to the virtuous circle of discovery, development and deliver,” said Neal F. Kassell, MD, the Chairman of Focused Ultrasound Foundation.
The 5th International Symposium on Focused Ultrasound takes place at the Marriott Hotel & Conference Center in Bethesda, Maryland from August 28 until September 1. The briefing on clinical advances in ultrasound will occur on Wednesday, August 31 from 1 p.m. until 2:30 p.m.
